SCHEMBL2941899

SCHEMBL2941899

C[Si](C)(C)I

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL216 1.00
SCHEMBL31401816 0.93
Iodide SCHEMBL7121770 0.93
SCHEMBL467649 0.83
SCHEMBL329453 0.83
SCHEMBL15173128 0.82
Methylene Chloride SCHEMBL6521187 0.78
Acetonitrile SCHEMBL2402422 0.74
SCHEMBL10360393 0.72
SCHEMBL18108160 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1726992-B1 NEGATIVE RESIST COMPOSITION TOKYO OHKA KOGYO CO LTD (JP) 2015-12-30 EP disclosed
US-7749677-B2 Negative resist composition TOKYO OHKA KOGYO CO., LTD. (JP) 2010-07-06 US disclosed
US-7439232-B2 Heteroaryl 5-thio-β-D-glucopyranoside derivatives and therapeutic agents for diabetes containing the same TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-10-21 US disclosed
US-20080241753-A1 Negative Resist Composition TOKYO OHKA KOGYO CO., LTD. (JP) 2008-10-02 US disclosed
EP-1726992-A1 NEGATIVE RESIST COMPOSITION TOKYO OHKA KOGYO CO., LTD. (JP) 2006-11-29 EP disclosed
US-20060194809-A1 Heteroaryl 5-thio-beta-d-gucopyranoside derivatives and therapeutic agents for diabetes containing the same TAISHO PHARMACEUTICAL CO., LTD. (JP) 2006-08-31 US disclosed
EP-1609799-A1 HETEROARYL 5-THIO-BETA-D-GLUCOPYRANOSIDE DERIVATIVES AND REMEDIES FOR DIABETES CONTAINING THE SAME TAISHO PHARMACEUTICAL CO., LTD (JP) 2005-12-28 EP disclosed